Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
An update from Vitrafy Life Sciences Ltd. ( (AU:VFY) ) is now available.
Vitrafy Life Sciences Limited announced that 5,205,280 of its fully paid ordinary shares, currently under voluntary escrow, will be released upon the publication of the company’s audited accounts for the financial year ending June 30, 2025. This release of shares may impact the company’s stock liquidity and market presence, potentially affecting stakeholders and investors as the company continues to enhance its position in the cryopreservation industry.
The most recent analyst rating on (AU:VFY) stock is a Buy with a A$2.00 price target. To see the full list of analyst forecasts on Vitrafy Life Sciences Ltd. stock, see the AU:VFY Stock Forecast page.
More about Vitrafy Life Sciences Ltd.
Vitrafy Life Sciences Limited is a company specializing in cryopreservation solutions, offering a proprietary range of smart cryopreservation hardware and a cloud-based software platform called Lifechain™. Their integrated system is designed to maintain the integrity of sensitive biological samples during storage, combining advanced technology with seamless software integration. Headquartered in Melbourne, Australia, Vitrafy operates an ISO13485 accredited manufacturing facility and laboratory in Ballarat, Victoria, and is listed on the Australian Securities Exchange (ASX: VFY).
Average Trading Volume: 25,671
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$102.2M
Find detailed analytics on VFY stock on TipRanks’ Stock Analysis page.